openPR Logo
Press release

Febrile Neutropenia Market: Majorly driven by the efforts of key players to develop novel and cost effective therapeutics

10-25-2016 12:11 PM CET | Health & Medicine

Press release from: TMR - MD

Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally, patient with febrile neutropenia is treated with prophylactic antibiotics to recover from persistent or recurrent fever conditions.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2857

The market of febrile neutropenia is majorly driven by the efforts of key players to develop novel and cost effective therapeutics. For example, in July 2014, Taiho Pharmaceutical Co., Ltd. filled an application for approval of ZOSYN 2.25 and ZOSYN 4.5 (generic name- tazobactam piperacillin) for additional indication of febrile neutropenia. This product is a combination of antibacterial β-lactamase inhibitor and can be used intravenously. Moreover, in April 2014, Amgen, Inc. collaborated with ONS Edge, Inc. to help educate nurses regarding the patients who are at the risk of febrile neutropenia.

Thus, these types of efforts will build healthy platform to develop the market of febrile neutropenia hence stimulates the market growth. Additionally, large number of therapeutics under clinical pipelines by key companies will further stimulate the market growth in near future. Positive initiatives by North American and European governments will further drive the market growth of febrile neutropenia. For example, in September 2013, U.S. Food Drug and Administration (U.S. FDA) approved phase III study of Neulasta (pegfilgrastim) by Amgen, Inc. This study demonstrates increase of white blood cells in patients who are undergoing myelo-suppressive chemotherapy. In addition, in June 2010, Nivestim (TM), a new biosimilar filgrastim by Hospira, Inc. is approved by European Commission. This drug is mainly used for the prevention of febrile neutropenia and offers cost-effective treatment option for neutropenia. However, lack of specific treatment that enables to treat all the symptoms of this disorder may restrain the growth of this market. In addition, high generic competition among the key players leads to price erosion and ultimately restrains the overall growth of febrile neutropenia market.

Read Full Report: http://www.transparencymarketresearch.com/febrile-neutropenia-market.html

The market of febrile neutropenia can be segmented on the basis of:
By Therapeutics Molecule Types
Pegfilgrastim
Vancomycin hydrochloride
Filgrastim biosimilars
Pegfilgrastim biosimilars
Stimuxen
Others
Geographically, North America dominates the global febrile neutropenia market. High degree of therapeutic needs for febrile neutropenia coupled with presence of large number of key players like Amgen, Inc., Aequus BioPharma, Inc. and others in North American market will drive the growth of the market. Europe is considered as the second largest market of febrile neutropenia. Large pool of patients under the diagnosis of this disease coupled with increasing demand of treatment fuels the growth of febrile neutropenia market. In addition, Asia-Pacific region is considered as an emerging market for febrile neutropenia due to the launch of novel drugs with improved efficacy by key companies. In addition, growing awareness for this disorder among the people will further stimulate the growth of febrile neutropenia market in Asia-Pacific region.

Some of the key players in the febrile neutropenia market include Xenetic Biosciences plc, Richter Gedeon Nyrt., Amgen, Inc., Hospira, Inc., Eli Lilly and Company, USV Limited, Aequus BioPharma, Inc., Taiho Pharmaceutical Co., Ltd. and others.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Febrile Neutropenia Market: Majorly driven by the efforts of key players to develop novel and cost effective therapeutics here

News-ID: 376157 • Views:

More Releases from TMR - MD

Technological Advancements in Endoscopic Procedures have Resulted in Several Imp …
Medical videoscopes help to enhance the visualization system during various surgeries enabling health care experts to closely observe body cavities and organs. Videoscopes contain specific software that creates dynamic 3D images from the output of computed tomography (CT), magnetic resonance imaging (MRI) and other scanners. The images are thereby used by health care professionals to improve the diagnosis of serious medical conditions. Medical videoscopes are usually 10 mm or lesser
Dental Pain Market is teeming with opportunities for established players as well as new entrants
Dental Pain Market is teeming with opportunities for established players as well …
A new research study by Transparency Market Research (TMR) provides a comprehensive assessment of the global dental pain market. The report, titled “Dental Pain Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” is available for sale on TMR’s website. According to the research report, the global dental pain market is teeming with opportunities for established players as well as new entrants. The market also provides
Glenoid Implant System Market: Strategies of key players and products offered
Glenoid implants are mainly used for hemiarthroplasty. Hemiarthroplasty involves replacing just the joint surface of the humeral head with a cap-like prosthesis without a stem. In shoulder replacement surgery, the damaged parts of the shoulder are removed and replaced with artificial components, called a prosthesis. The treatment options are either replacement of just the head of the humerus bone (ball), or replacement of both the ball and the socket called
Vital Signs Patch System Market: Future market projections for forthcoming years
Vital Signs Patch System: Overview Beginning of wireless technologies and advancements in on and of body sensor design can empower change in the vital signs patch system market. Monitoring of vital signs, such as respiration rate, body temperature, pulse rate is a crucial component of patient valuation and assessment. Changes in vital signs can be indicators of failing in a patient’s condition. Vital signs patch system is a sensor (cable

All 5 Releases


More Releases for Amgen

Biopharmaceutical Market 2023 | Emerging Technologies, Business Trends | Amgen I …
The strategy analysis on Global Biopharmaceutical Market gives insights of market size, trends, share, growth, development plans, Investment Plan, cost structure and driver's analysis. With precise data covering all key aspects of the existing market, this report offers existing data of leading manufacturers. The Biopharmaceutical Market report covers marketing channels and market positioning to potential growth strategies, providing in-depth analysis for new competitors or existing competitors in the Biopharmaceutical Industry. The
Oncology Biosimilars Market Analysis 2020: Pfizer, Amgen, Allergan
The rising technology in Oncology Biosimilars Market is also depicted in this research report. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail. This is the most recent report that includes the effects of COVID-19 on the functioning of the market. It is well known that some changes, for the worse, were managed by the pandemic
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Biotechnology Market Competitive Landscape with Amgen Inc, Amgen Inc, Celgene, M …
Biotechnology Market to exceed USD 775 billion by 2024 as per a new research report. Favorable government initiative and growing demand for synthetic biology will drive the biotechnology industry growth over the forecast timeframe. Also rising demand for agro-based products should fuel global biotechnology market growth. Decreasing cost of DNA sequencing from last couple of decades owing to the advances in the field of genomics will stimulate the global biotechnology market. Furthermore,
Ticagrelor Market 2027 Top Key Players are AstraZeneca, Eli Lilly, Boehringer, I …
MRFR is the Leading Brand in The Research Company who Recently Published Ticagrelor Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2027. Global Ticagrelor Market - Overview Ticagrelor is an antiplatelet drug which is a member of a section of pharmaceuticals which tackle the problem of platelet aggression. The Global Ticagrelor Market is expected to grow at a healthy
2018 Biologic Drugs Market Future by Manufacturers- Roche, Abbott Laboratories, …
Download PDF Sample @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1656420 The Global Biologic Drugs Industry Report 2018 is a professional and in-depth study on the current state of the Biologic Drugs Market. Key Companies Analysis- Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Pfizer, Amgen, Sanofi, Novartis, Eli Lilly, Amgen Complete report on Biologic Drugs market spread across 94 pages, profiling 10 companies and supported with